Debin Wang – Trademark Portfolio

Entity Type: 01

Debin Wang holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ANHANA, JURTAY, RYBARA, and TAVDAT. The owner is based in Yichang City, Hubei.

Zhicheng Town, Yidu City,

Group 4, Baishuigang Village,

Yichang City, Hubei 443311 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TAVDAT
TAVDAT
Registered 2024
JURTAY
JURTAY
Registered 2024
ANHANA
ANHANA
Registered 2024
RYBARA
RYBARA
Registered 2024

Trademark Classifications

Debin Wang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

12
Vehicles (2 filings)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Debin Wang have?

Debin Wang has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Debin Wang file in?

Debin Wang files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 12 (Vehicles). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Debin Wang's most well-known trademarks?

Debin Wang's registered trademark portfolio includes well-known marks such as ANHANA, JURTAY, RYBARA, and TAVDAT. These are among 4 currently registered trademarks in the portfolio.

What is Debin Wang's trademark registration success rate?

Debin Wang has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.